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Abstract 
The evolution of micro and nanofabrication approaches significantly spurred the advancements of cardiac 
tissue engineering over the last decades. Engineering in the micro and nanoscale allows for the rebuilding 
of heart tissues using cardiomyocytes. The breakthrough of human induced pluripotent stem cells 
expanded this field rendering possible the development of human tissues from adult cells, thus avoiding 
the ethical issues of the usage of embryonic stem cells but also creating patient-specific human engineered 
tissues. In the case of heart, the combination of cardiomyocytes derived from human induced pluripotent 
stem cells and micro/nano engineering devices gave rise to new therapeutic approaches of cardiac 
diseases. In this review, we survey the micro and nanofabrication methods used for cardiac tissue 
engineering, ranging from clean room-based patterning (such as photolithography and plasma etching) to 
electrospinning and additive manufacturing. Subsequently, we report on the main approaches of 
microfluidics for cardiac culture systems, the so-called  “,ĞĂƌƚŽŶĂŚŝƉ ?, and we assess their efficacy for 
future development of cardiac disease modeling and drug screening platforms. 
 
Keywords: cardiac tissue engineering, micro/nanofabrication, polymeric scaffold, microfluidics, heart-on-a-
chip 
  
1. Introduction 
/Ŷ ? ? ? ?:ŽƐĞƉŚsĂĐĂŶƚŝ ?ƐĂŶĚZŽďĞƌƚ>ĂŶŐĞƌ ?ƐŐƌŽƵƉƐ[1] transplanted biodegradable polymer-cell artificial 
three-ĚŝŵĞŶƐŝŽŶĂů ? ? ?ƐĐĂĨĨŽůĚƐŝŶƚŽĂŶŝŵĂůƐ ?dŚĞŝƌĂƉƉƌŽĂĐŚ ?ŶĂŵĞĚ “ĐŚŝŵĞƌŝĐŶĞŽŵŽƌƉŚŽŐĞŶĞƐŝƐ ? ?ǁĂƐ
based on the idea of remodeling and self-regulation of tissue. The transplanted patch would only provide a 
means of initial support (similar to a scaffold) for cells and then dissolve. Later on [2], Vacanti explained the 
reasons why there is a huge and increasing need of artificial organs, and  why surgeons struggle to address 
the problem of lack of donors especially for infants and very young children. Introducing how nature copes 
with problematic situations on pathologies of organs, he proposed the biomimetic approach of 
ƚƌĂŶƐƉůĂŶƚŝŶŐ Ă  “ĐŚŝŵĞƌŝĐ ? ĐŽŵƉŽƐŝƚĞ ƉĂƚĐŚ ĚŝƌĞĐƚůǇ ŽŶ ƉƌŽďůĞŵĂƚŝĐ ĂƌĞĂƐ ŽĨ ŽƌŐĂŶƐ ? dŚŝƐ ƉĂƚĐŚ ǁĂƐ Ă
composite material made from polymers and seeded in vitro with cells. Polymers, he claimed, could be 
modified in terms of composition to achieve desired mechanical and chemical properties, and promote not 
only biocompatibility, but additionally cell attachment with the aid of surface modification methods. Langer 
and VacantŝƌĞŶĂŵĞĚƚŚĞŝƌĂƉƉƌŽĂĐŚ ?ĂŶĚƚŚĞŝĚĞĂŽĨ “ƚŝƐƐƵĞĞŶŐŝŶĞĞƌŝŶŐ ?ǁĂƐŝŶƚƌŽĚƵĐĞĚ[3]. This altered 
approach expanded even more, to the use of synthetic and natural polymers as well as composite materials 
and mixtures. Their idea signalled the need for true interdisciplinary research, novel advancements in 
materials and polymer science, pioneer fabrication methods having dual or triple scale capabilities that 
extend from nano to centimeter scales, if this idea of engineering a tissue or an organ would have any 
chances to be materialised and be successful. 
On the other hand, advances in micro-nanofabrication and microfluidics have opened the repertoire of 
applications in life sciences including not only diagnosis but also disease modeling and therapeutic 
approaches. The field of microfluidics and lab-on-a-chip (LoC) devices stems from the areas of molecular 
analysis, biodefence, molecular biology, and microelectronics according to Whitesides [4]. Regarding the 
LoC devices development, the first ones were fabricated by standard photolithographic techniques in 
silicon, adapted from microelectronics and MEMS (micro electro mechanical systems) research. Over the 
years, silicon and later glass were gradually replaced by polymeric materials, taking advantage of their low 
cost and customizable material characteristics, enabling their manufacturing with a plethora of methods 
[5]. Starting from optical lithography and clean room facilities for fabrication of chips based on SU-8, the 
development of rapid prototyping techniques stirred their evolution in a more affordable and fast manner. 
Likewise, cell culture substrates  benefited from microelectronics: while in transistors fabrication of a rough 
surface due to reactŝǀĞŝŽŶĞƚĐŚŝŶŐǁĂƐĨĂƚĂů ?ƚŚŝƐ  “ĨĂŝůƵƌĞ ? Žƌ “ƵŶǁĂŶƚĞĚ ?ƐŝĚĞĞĨĨĞĐƚŽĨĂƚĞĐŚŶŝƋƵĞ ? was 
proven to be beneficial in cell cultures were nano and microtopography acts as a spatial cue for promoting 
cell adhesion and proliferation [6]. 
Consequently, tissue engineering and regenerative medicine have significantly flourished over the last 
decades, due to the progress of micro and nano-engineering. dŚĞĂƌĞĂŽĨ  “KƌŐĂŶŽŶĂŚŝƉ ?ĐŽŶƐŝƐƚƐƚŚĞ
most recent and challenging topic of LoC devices, where microfluidics and cell cultures are combined in 
providing an in vivo-like environment. Towards this direction, in this review we emphasize in the advances 
ĨŽƌƚŚĞĚĞǀĞůŽƉŵĞŶƚŽĨ “KƌŐĂŶŽŶĂŚŝƉ ?ƐǇƐƚĞŵƐ ĨŽĐƵƐŝŶŐŽŶŚĞĂƌƚ ?ƚŚĞƐŽĐĂůůĞĚ “,ĞĂƌƚŽŶŚŝƉ ? ?ǁŚŝĐŚ
importance is underlined by the high evolution in research concerning cardiac tissue engineering and 
regenerative medicine. The first part covers the main micro-nano fabrication methods that have been 
utilized for the development and improvement of cardiac tissue engineering. The second part focuses on 
presenting the last advances of combining the in vitro cardiac tissues with microfluidics for the creation of 
higher degree-integrated  “,ĞĂƌƚŽŶĂŚŝƉ ? systems for cardiac disease modeling and drug screening. The 
advent of induced pluripotent stem cells (iPSCs) from adult cells by Shinya Yamanaka in 2006 [7] gave a 
further boost in the field, rendering possible the generation of cardiomyocytes (CMs) derived from human 
iPSCs (hiPSC-CMs), thus providing with patient-specific cardiac cells. 
 
2. Micro and nanoengineering methods used for cardiac tissue engineering 
The extracellular matrix (ECM) environment plays a significant role in cell behaviour, functionalities and 
viability [8 W10]. Cardiac cells are no exception to the rule [11,12]. Substrates with controlled architectures 
can provide critical information on the study of the cell-material interactions on adhesion and on other 
(relevant to adhesion) properties such as orientation, shape, viability, migration. By understanding and 
decoding the dominant mechanisms on cell-material interactions we could then provide the necessary 
properties to mimic the microenvironment of the heart [10,13,14]. It is obvious that in order to be able to 
study the aforementioned interactions, a total control on the micron and nano size features of the surface 
of the culture interface, between cells and materials must be set. Micro and nanofabrication and materials 
engineering have traditionally tackled with controlling and fabricating structures at these scales and they 
are the ones that have been called out to give the answers on providing artificial platforms with a top level 
of control on the chemistry, topography, elasticity, conductivity and other useful properties [5,15 W20]. 
 
2.1 Optical Lithography 
Optical lithography or photolithography is the most widespread micro/nanofabrication method. It has been 
used in micro/nanoelectronics and MEMS, as well for the fabrication of LoC devices using a top-down 
approach [5]. It uses light (UV, or DUV) going through a mask and transfers a desired pattern on a 
photosensitive material [21] [15]. The patterned polymer is subsequently used as a mask for transferring 
this pattern on a substrate with plasma etching. Although this is a multistep process, it is very well 
controlled and defined, and can be versatile in terms of combination with other techniques. It has been 
found that cells can be cultured directly on top of electrodes, printed circuit boards, as well as other 
micro/nanoelectronic elements, since SiO2, Cu, Au, Pt, glass, quartz, Kapton, polyimide and most of the 
materials of the substrates of micro/nanoelectronic and MEMS proved to be not only compatible to the 
cells but in some cases were favorable towards specific functionalities [22].  
In the case of cardiomyocytes (CMs) and cardiac tissue, the most profound example is the one of the 
microelectrode array (MEA) that is used for evaluating arrhythmias [23,24], while similar apparatus has 
been used for single cell detection of cellular activity [25]. Perfectly aligned arrays of long silicon nanowires 
fabricated using a complementary metal oxide semiconductor (CMOS) compatible approach and configured 
as field-effĞĐƚ ƚƌĂŶƐŝƐƚŽƌƐ ? ĚĞŵŽŶƐƚƌĂƚĞĚ ĂŶ ĂďŝůŝƚǇ ĨŽƌ ƌĞĂů ?ƚŝŵĞ ĞǆƚƌĂĐĞůůƵ Ăƌ ƌĞĐŽƌĚŝŶŐ ŽĨ ĐĞůůƵůĂƌ
bioelectricity, enabling non-ŝŶǀĂƐŝǀĞ ? ŚŝŐŚ ?ƐĞŶƐŝƚŝǀŝƚǇ ? ŚŝŐŚ ?ƚŚƌŽƵŐŚƉƵƚ ? ůŽŶŐ ?ƚĞƌŵ ĞůĞĐƚƌŽƉŚǇƐŝŽůŽŐǇ
ŵĞĂƐƵƌĞŵĞŶƚƐ Ăƚ ƚŚĞ ƐŝŶŐůĞ ?ĐĞůů ? ƚŝƐƐƵĞ ĂŶĚ ŽƌŐĂŶ ůĞǀĞůƐ[26]. The use of MEAs for the examination of 
cardiac responses was aimed to be used for drug screening purposes.  
Optical lithography is also used to direct the attachment and the shape of cells which are grown on 
surfaces. It has been found that when cardiac cells are cultured on surfaces that have been patterned into 
having typically 20 ʅm wide lines, cells tend to align and stretch their ECM and their nucleus towards the 
length of the line [27]. Aligning CMs is crucial for the contraction and propagation along the long axis [28]. 
Jain et al. fabricated micron sized ridges on a silicon surface as a model to study cardiac failure of diverse 
origin, achieving stretching and alignment of cultured cells [29]. Yamaguchi et al. have selectively modified 
and patterned APTES-COOH surfaces with the help of Vacuum UV photolithography. The selective linear 
local surface chemical modification, created a patterned culture of primary rat cardiac cells [30]. 
Khademhosseini group developed various systems based on gelatin methacryloyl (GelMA) hydrogels [31]. 
GelMA hydrogels are photocrosslinkable and their mechanical properties can be adjusted to native ECM 
ones, while they can be microfabricated with various methods, rendering them a versatile material for 
tissue engineering. For example, they developed a coating method of PDMS-based microfluidics with 
GelMA and methacrylated tropoelastin (MeTro) for improving CMs attachment and organization inside the 
channels [32]. By adjusting the injection flow rate of the prepolymer solution during UV crosslinking, a 
controllable coating thickness was achieved. Nevertheless, culture of neonatal rat CMs showed that they 
are better attached and beating on the MeTro coatings. 
 
2.2 Soft lithography 
Soft lithography is a name attributed to a plethora of related techniques. These techniques are used for 
micro/nanopatterning and their common characteristic is that they involve fabrication or replication of a 
 “ŵĂƐƚĞƌ ? ?dŚŝƐŵĂƐƚĞƌĐĂŶĞŝƚŚĞƌďĞƵƐĞĚĂƐĂ stamp or as a mold to pattern an elastomer, which is later 
cross-linked. After cross-linking, the patterned elastomer is used as a stamp/mold for the 
micro/nanopatterning of other materials. The name of the method was initially introduced due to the fact 
that it uses elastomeric materials, with the most notable one being polydimethylsiloxane (PDMS) [5]. It 
should be noted that optical lithography, electron beam, laser patterning or other microfabrication 
methods are used for the fabrication of the initial stamp or mold. Since cells and tissue are not grown in 
direct contact with the masks but with the materials that are patterned at later steps of this process, they 
do not provide any additional functionality and thus they are not categorised separately in this study. An 
exception to this rule is the work by Badie et al. which used diffusion tensor magnetic resonance imaging 
(DTMRI) to image and translate the directionality of cardiac tissue into a lithography photomask [33]. 
Optical lithography followed for the transfer of this pattern on a photoresist over a silicon wafer. This was 
used as a mold for a PDMS by a soft lithography approach to pattern fibronectin on a coverslip, which 
would be used as a surface for the control of culture of CMs. This approach can aid in the understanding of 
the complex role of cardiac microarchitecture on healthy or remodelled systems in macroscopic impulse. 
In the case of cardiac cells and tissue engineering, soft lithography is by far the most widely employed 
technique for the micro/nanopatterning of surfaces. Beussman et al. fabricated PDMS micropost arrays, 
functionalised with ECM protein to measure the contractility of stem cell derived CMs [34]. Others modified 
the surface of posts or pillars to achieve a better response or a desired control on the attachment of cardiac 
cells [35 W38]. 
  
 
 
Figure 1. Formation of realistic cell alignments in micropatterned cultures. Schematic representation of the fabrication 
method (left) and immunostaining results (right). Red: sarcomeric a-actinin, green: connexin-43, blue: nuclei. Scale 
bars: (a Wc) 250 ʅm; (d) 50 ʅm. Reprinted with permission from [33]. 
 
Micro-scale grooves fabricated with soft lithography can significantly enhance cell alignment as was the 
case with optical lithography [39,40]. Additionally, alignment of CMs lead to a greater expression of cardiac 
genes and CMs markers, and gap junctional proteins such as connexion-43 [41,42]. Kim et al. [43] 
fabricated nanosized arrays using polyethylene glycol (PEG) hydrogel in an effort to reconstruct aligned 
fibrils. CMs were found to align along the direction of the topography, with analysis showing that this was 
due to the alignment of the focal adhesions. Many other studies followed similar approaches to promote 
desired functionalities for CMs by either micro/nanopatterning hydrogels and elastomers, or by printing a 
thin layer of micro/nanopatterned natural polymers to guide cardiac cells (such as collagen, gelatin, 
fibronectin, laminin, agarose or similar) [44,45,54 W57,46 W53]. 
Feinberg and Parker used soft lithography to tailor a nanofabric containing fibronectin, laminin, collagen 
type I and collagen type IV, which mimics the ECM. They have shown that cardiac cells cultured on the 
fabric could functionally organise cells into anisotropic tissue, including papillary threads, without any 
degradation [58]. Boateng et al. demonstrated that arrays of microposts (which they called micropegs) 
having 10µm tall extruded cylinder provided a vertical surface for cell attachment and greatly hindered the 
proliferation of fibroblasts comparing to smooth flat substrates [59]. This is a very interesting finding due to 
the well-known problem of separating CMs from fibroblasts and other non-myocyte cells, from the primary 
cell source. The reason behind this behaviour of fibroblasts was determined to be the extensive elongation 
of their nuclei, which resulted in a decreased proliferation rate [60].  
Stem cell differentiation was also found to be controlled by the effect of nanotopography (nanopillars and 
nanogrooves) created by soft lithography. This nanotopography-induced differentiation showed that with 
the control of the size and the distance of the nanostructures, the stem cells differentiated into different 
kind of cells including beating CMs. This is a promising but still very immature study, which faces many 
problems that need to be addressed (for example homogeneity) [61 W63]. 
 
2.3 Laser based fabrication 
The use of laser based fabrication techniques is becoming more widespread over the years. Lasers have the 
ability to modify a variety of materials in the micro and nano scale in a very controlled manner with the aid 
of robotic arms and computer controllers [64]. This part of the paper will only focus on planar fabrication 
techniques and thus will narrow down mainly to laser ablation. Laser ablation as a technique uses a focused 
laser beam to etch away material from the bƵůŬ ?ďǇĚŝƌĞĐƚůǇ “ǁƌŝƚŝŶŐ ?ƚŚĞĚĞƐŝƌĞĚƉĂƚƚĞƌŶ[65]. It is common 
for use in various biological applications due to the fact that the laser beam causes vaporisation of the 
material with no sign of any thermal effects [66]. Patz et al. used excimer laser ablation to directly fabricate 
channels on agarose, and showed improved attachment, alignment, proliferation and differentiation of 
C2C12 myoblasts [67]. Similar approaches have been used for the modification of other soft matter [68,69]. 
The same approach was used by Engelmayr et al. for the production of multi-layered elastomeric scaffolds 
ǁŚŝĐŚŚĂĚĂŶ “ĂĐĐŽƌĚŝŽŶ-like honeycomb structure ? ?dŚŝƐĂůůŽǁĞĚƚŚĞŵƚŽŵŝŵŝĐƚŚĞƐŚĂƉĞŽĨƉĞƌŝŵǇƐŝĂů
collagen fibers, as well as to guide the alignment of cells and to replicate the native myocardium tissue 
microenvironment and anisotropy [70 W72][73]. With this method the group managed to fabricate 
membranes which matched the anisotropic mechanical properties of the left ventricular tissue, which could 
sustain cyclic loads and additionally promote desired synchronous contraction, and directionality of cells on 
the heart circumferential axis [70]. The same approach was used by Kapnisi et al. for creating auxetic 
cardiac patches [74]. 
Laser interference lithography is a technique that takes advantage of the periodicity of the interference 
pattern between two or more light (laser) waves, using this as a way to expose a photoresist (similar to 
optical lithography). This pattern creates well defined structures [75]. For example, Fujita et al. controlled 
CMs orientation using patterns created by this technique [76]. 
Lasers were also used, in more exotic approaches, as a tool for the deeper understanding of the 
mechanisms and role of specific type of cardiac cells. For example, Narasimhan et al. demonstrated optical 
ŵĂŶŝƉƵůĂƚŝŽŶŽĨĐĞůůƐƵƐŝŶŐĂǁĞĂŬůǇĨŽĐƵƐĞĚůĂƐĞƌďĞĂŵ ?dŚĞǇĚŝƌĞĐƚĞĚĂŶĚĐƌĞĂƚĞĚĂ “ďƌŝĚŐĞ ?ŽĨĨŝďƌŽďůĂƐƚƐ
in between two lines of cultured myocytes, which were beating asynchronously, to understand the 
electrophysiological role of the fibroblasts [77] . 
 
2.4 Plasma surface modification 
In the last ten years, the use of low vacuum, and atmospheric pressure plasma systems has had an 
outburst. There are many studies that show how plasmas can be used for the stochastic and periodic nano 
and micro scale structuring of surfaces, with a simultaneous modification of the surface chemistry. Due to 
this duality, plasmas have been used to achieve a desired functionalization of surfaces [78]. As mentioned 
in the introduction, surface modification was one of the first key components that were identified from the 
very beginning as essential in mimicking successfully the micro/nanoenvironment of an organ, and in our 
case the myocardium, or any other part of the heart [2,3]. Apart from the control of wettability [19], 
reflectivity [79], plasma surface modification has been used for the immobilisation of proteins on surfaces 
[17,80] or for the control of attachment, shape and behaviour of various cells [8,9].  
In the case of cardiac cells, plasma functionalization of surfaces is mostly used in combination with other 
techniques to improve the hydrophilicity of a surface which will be used for the CMs culturing 
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[49,56,71,81 W86]. Parker group has used oxygen plasma to control the attachment of gelatin hydrogel on 
cyclic olefin copolymer, cyclo olefin polymer and polyolefin surfaces. These were subsequently used to 
validate their suitability for cardiac tissue engineering, using both primary neonatal rat CMs and hiPSC-CMs 
[47]. Brown et al. investigated the effect of plasma surface modification for the absorption of fibronectin on 
poly(lactic-co-glycolic acid) (PLGA) substrates using neonatal rat ventricular CMs. Their study showed 
improved spreading and myofibril development on the plasma modified samples, and also that the protein 
absorption affects the gene expression of the attached cells [87]. Guex et al. used plasma to deposit an 
oxygen functional hydrocarbon coating on ɸ-polycaprolactone (PCL) nanofibers. This improved the 
mechanical stability and endurance of the nanofibers while tested in vivo in a rat model [88]. Kontziampasis 
et al. have used O2 and Ar plasma etching to investigate the effect of nanotopography and chemistry 
changes induced on Parylene C films [89]. These were used to control the viability of neonatal rat CMs. 
Despite the fact that O2 plasma rendered the surfaces more hydrophilic, the Ar plasma led to a more-
friendly chemistry of the surface, allowing neonatal rat CMs to grow better on the Ar plasma treated ones.  
 
2.5 Electrospinning 
Electrospinning is a technique that is widely used for the fabrication of nanofibers, using polymeric 
(bio)materials or (bio)polymer based composites [13,90,91]. Currently it is the technique that is most 
widely used in industrial applications due to its ability to upscale, with many systems being developed in 
the last few years [92]. In electrospinning, a solution is fed through a capillary while opposite a collector 
which is grounded. High voltage is applied and thus a jet of the solution travels from the needle to the 
collector, where it deposits dried nanofibers. By adjusting the process and material parameters as well the 
environmental conditions, nanofibers characteristics can be modulated [93]. Due to its cost effectiveness as 
well as its simplicity, this method has become very popular for many biological applications.  
Since electrospun nanofibers show similar morphologies with the natural ECM, which consists of long 
continuous fibers of several different diameters, tissue engineering and especially cardiac tissue 
engineering have shown a great interest to it. The need for aligned nanofibers has led to advancements on 
the collector, with several approaches like a high-speed collecting drum or a mandrel collector being 
developed [94,95]. There is a plethora of natural and synthetic polymers that are used for cardiac tissue 
engineering related electrospinning, as it was recently reported by Kitsara et al. [13]. In order to mimic 
correctly the mechanical properties, conductivity, elasticity as well the local chemistry of the 
microenvironment of the myocardium, several different approaches have been developed trying to 
improve the biomimicry of the electrospun fabricated scaffolds. The first one is the electrospinning of 
composite materials which either were a mixture of a natural and a synthetic polymer, or a polymeric 
solution on which other additives were added. Gold nanoparticles [96 W99] and carbon nanotubes [100 W
103] were added in order to improve the conductivity of the electrospun construct in several cases. 
Peptides [104] and granulocyte colony-stimulating factor [85,105,106] was added in some studies to 
improve the remodeling and viability of CMs.  
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Figure 2. Cardiac differentiation of hiPSCs on patch consisted of a monolayer of electrospun gelatin nanofibers in a 
honeycomb fabricated PEGDA frame. (A), (B) Schematic and protocol of cardiac differentiation. (C) Bright-field images 
of the differentiating hiPSCs at different days. Reprinted with permission from [107].  
 
Tian et al. [108] fabricated core-shell nanofibers using an emulsion (instead of a solution) for 
electrospinning, encapsulating a bioactive growth factor for cardiovascular regeneration (VEGF) in dextran 
or bovine serum albumin (BSA). In vivo studies showed that most of the transplanted myocytes prevented 
negative ventricular remodeling, while expressing the cardiac marker proteins [109]. In another study, 
introducing VEGF in electrospun nanofibers provoked angiogenesis and cardiomyogenesis in an acute 
myocardial infarction rat model [110]. Tang et al. fabricated a honeycomb shaped frame with poly(ethylene 
glycol) diacrylate (PEGDA) and electrospun a monolayer of gelatin nanofibers on top. Induction and 
differentiation of hiPSC was performed on the same scaffold, which led to a uniform cardiac tissue with 
homogeneous beating (figure 2) [107]. Li et al. [111] electrospun a very thin layer of PLGA nanofibers on a 
PDMS frame, and showed that it promoted the maturation of hiPSC-CMs. They evidenced their results by 
measuring an increased electrical response comparing to the same CMs cultured on a flat surface, and 
validated this finding with flow cytometry, immunostaining, and qPCR, which showed that the construct 
upregulated cardiac biomarkers and enhanced cardiac functions. They named the hybrid nanofiber-CM on 
ƚŚĞWD^ĨƌĂŵĞĂƐ “ĐĂƌĚŝĂĐƚŝƐƐƵĞ-like construct  ?d> ? ? ?The CTLC was used for in vitro experiments where 
it managed to connect and synchronize the beating of two disconnected CM tissues. In vivo experiments in 
rat models of myocardial infarction, showed that the CTLCs with a high number of cells and increased 
thickness could surpass the problem of the high Young modulus of the PLGA fibers.  
The group of Javasinghe have managed to directly electrospin living cells for the development of scaffolds 
ǁŝƚŚ  “ůŝǀŝŶŐ ?ƉĂƌƚƐ[112]. In order to be able to realise the technique they used a coaxial needle where a 
concentrated biosuspension flows through the internal needle, while high viscus and low electrical 
conductivity polymeric medium (in this case PDMS) flows in the external part, showing that cells were not 
affected from the high voltage. In a more recent study they used primary neonatal CMs to fabricate living 
scaffolds with cell electrospinning, while maintaining their functionalities [113].  
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Figure 3. Basic micro and nanoengineering methods used in cardiac tissue engineering. Schematic representations of 
the method, followed by advantages and disadvantages for their use in cardiac tissue engineering. Figures (reprinted 
with permission) are modified from the following: optical lithography from [21], soft lithography from [34], laser 
ablation from [64], plasma modification from [114],  and electrospinning from [90]. 
 
 
2.6 Additive manufacturing  
Additive manufacturing, also known as 3D printing, is the name attributed to a group of techniques. In 
1986, Charles Hull invented a process called 3D stereolithography [115]. Using this technique, it became 
possible to fabricate complex 3D objects that were not possible to be fabricated with any other method. 
The common basic principle under all additive manufacturing methods, is the modification or addition of 
consecutive 2D planes in order to achieve a 3D structure [116].  
3D printing has been employed by research and industry to create sophisticated instruments and tools. One 
of the most noticeable examples is its use for fabricating 3D surgical planning models, where a printed 
organ was fabricated as a guide for surgeons to identify and resolve problems and malfunctions before 
surgery. This has been used in heart surgery creating a replica of a ƉĂƚŝĞŶƚ ?Ɛ ŚĞĂƌƚ ĨŽƌ the precise 
understanding of the anatomy, hands-on simulation of surgical and interventional procedures, and 
morphology teaching of the medical professionals (figure 4) [117]. 
 
 
Figure 4. 3D printed cardiac models for surgical practice or training. Reprinted with permission from [117]. 
 
In the last few years, tissue engineering and regenerative medicine are showing great interest in the use of 
3D printing, and have started to investigate its potential to directly print scaffolds, tissue, and subsequently 
ŽƌŐĂŶƐ ? dŚŝƐ ƐƉĞĐŝĂůŝƐĞĚ ĂĚĚŝƚŝǀĞ ŵĂŶƵĨĂĐƚƵƌŝŶŐ ŚĂƐ ďĞĞŶ ŶĂŵĞĚ ĂƐ  “ďŝŽƉƌŝŶƚŝŶŐ ? ? which includes three 
steps; pre-bioprinting, bioprinting itself, post-bioprinting. Pre-bioprinting is the step where scanning and 
imaging, computer aided design and material selection take place. Scanning usually is done either by 
magnetic resonance imaging or by computer tomography, while material selection is dependent on the 
type of the printing technique as well as the final aimed construct. Bioprinting in principle works as a typical 
desktop printer. It uses the (3D) printer, (bio)ink and a biomaterial instead of paper. Post-bioprinting 
involves all the processes that are needed to acquire a 3D biological structure with the appropriate 
properties and biological functionality. This for example includes the maturation time of the printed 
construct in order to fuse different planes into one structure  [118].  
Bioprinting can be realised by using several approaches, but the ones that are most widely used for 
depositing and patterning biological materials are laser-assisted printing, multiphoton excitation (MPE) W
based fabrication (stereolithography), inkjet printing, and microextrusion. Schematics of these approaches 
as well as advantages and disadvantages are shown in figure 5 [119,120,129 W133,121 W128].  
 
 Figure 5. Schematic representations of the four most widely used techniques of 3D printing for cardiac tissue 
engineering (reprinted with permission and modified from [121]). (A) Laser-assisted bioprinting (LAB) which is based 
on laser-induced forward transfer (LIFT). (B) Multiphoton excitation (MPE) which is also called stereolithography. (C) 
Inkjet printing. (D) Microextrusion ink deposition. The basic advantages and disadvantages for each method for 3D 
bioprinting are cited below each schematic.   
 
Parker group 3D-printed various different cardiac microphysiological devices with integrated sensors, which 
were inside their customised inks (described in the section 3.2, figure 6c). This approach showed to 
improve the ability of tracking temporal development of the mechanics of the tissue and promises to 
enable new insights for tissue morphogenesis, pathogenesis, as well as drug induced remodeling [134]. 
Gaetani et al. [135] bioprinted alginate with human CM progenitor cells, fabricating a construct which 
possessed high cell viability (92% and 89% at 1 and 7 days of culturing). The constructs retained the cardiac 
lineage, showing an enhanced expression of genes and early cardiac transcription factor sarcomeric 
protein. Cells were reportedly migrating from the construct matrix to form a tubular structure and colonize 
on a matrigel layer. The same group [136] also demonstrated tissue printing of an hyaluronic acid/gelatin 
(HA/gel) scaffold combined with human fetal CM progenitor cells. This was proposed as a cardiogenic patch 
with defined pore size that could promote cell viability.  
Gaebel et al. [137] fabricated a cardiac patch, with LIFT cell printing using human umbilical vein endothelial 
cells (HUVECs) and human mesenchymal stem cells (hMSCs) on a defined pattern. Performing an in vivo 
study they showed that the transplantation of the tissue engineered cardiac patch had an increased vessel 
formation, and a significant improvement in density of the infarcted heart. Cells were integrated into the 
vessels of the murine vascular system, showing that the patch is a promising approach towards the 
treatment of myocardial infarction. Izadifar et al. used an alginate laden with human coronary artery 
endothelial cells as ink for the layer by layer bioprinting of cardiac constructs with varying architectures 
performing in vivo studies as well as implantation on rat hearts. For the in vivo studies the constructs 
offered a high cell viability and distribution, while the implanted constructs showed a good agreement with 
the in vitro measurements in terms of impedance or elastic modulus [138]. Adams et al. [139] printed 
scaffolds from PCL using a commercial microextrusion 3D printer, and incorporated wirelessly controlled 
electrical stimulators. Electrical stimulation showed signs of improving the attachment and provoking 
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differentiated actin cytoskeletal structures. Ho et al. [140] also used 3D printing with a PCL - carbon 
nanotube composite, while comparing the viability with a PCL scaffold in the case of rat myoblasts (H9C2). 
Gao et al. [141] used MPE for fabricating a scaffold, based on photoactive gelatin polymer, with submicron 
resolution which they seeded with CMs, smooth muscle cells and endothelial cells. All cells were 
ĚŝĨĨĞƌĞŶƚŝĂƚĞĚĨƌŽŵŚŝW^ƐĂŶĚĨŽƌƚŚŝƐƌĞĂƐŽŶƚŚĞǇŶĂŵĞĚƚŚĞŝƌĐŽŶƐƚƌƵĐƚĂƐ “human-induced pluripotent 
stem cell W derived cardiac muscle patch (hCMP) ? ? dŚĞ ƉĂƚĐŚ ǁĂƐ ĞǀĂůƵĂƚĞĚ ŝŶ Ă ŵƵƌŝŶĞ ŵŽĚĞů ŽĨ
myocardial infarction. In vivo results showed that hCMP improves cardiac function and reduces infarct size 
after myocardial infarction. The rate of cell engraftment in hCMP-treated animals was 24.5% at week 1 and 
11.2% at week 4. Ciocci et al. [142] fabricated a multitextured 3D PEGDA-based scaffold with 
microstereolithography, to induce a favorable microenvironment which promotes human cardiac 
progenitor cell differentiation and orientation. While cultured, cells adopted and showed a 3D spatial 
ordered orientation, while the expression of sarcomeric ɲ-actinin and connexion-43 was activated.   
3D bioprinting shows also potential for fabricating heart valves. The common strategy for creating 
replacement heart valves is the surgical implantation of a mechanical or chemically crosslinked tissue heart 
valve [143], which is robust and show extended life-times [144]. Patients with a prosthetic valve, though, 
are required to permanently take anticoagulants, while when biological valves are implanted, they do not 
require their use [145]. Neither synthetic nor biological transplants grow and remodel with the patient. A 
3D bioprinted valve could possibly address these limitations. Most of the bioprinted heart valves have been 
fabricated using an extrusion type 3D bioprinter, using photo-crosslinkable hydrogels. Usually a 
ĐŽŵďŝŶĂƚŝŽŶ ŽĨ Ă  “ƐŽĨƚ ? ĂŶĚ Ă  “ƌŝŐŝĚ ? ŚǇĚƌŽŐĞů ŝƐ ďĞŝŶŐĞŵƉůŽǇĞĚ ƚŽ fabricate the leaflets and the root 
respectively [146]. This ability to print two different biomaterials allowed for the better biomimicry of the 
stiffness of different parts of the valve. Interstitial cells from porcine aortic valve survived for up to 3 weeks 
inside 3D bioprinted heart valves [147]. In another study from the same group, aortic root sinus SMCs and 
aortic valve leaflet interstitial cells were encapsulated into the root and leaflet portions of an 
alginate/gelatin 3D bioprinted aortic valve conduit. The study showed that valve leaflet interstitial cells 
remodeled hydrogels, by depositing collagen and glycosaminoglycan-based ECM [148]. Despite progress 
shown, heart valve 3D bioprinting has not managed to report results on functional testing of any of the 
printed valves up to date. 
Despite the great advancements of bioprinting techniques and despite the aforementioned 3D printed 
organ models (for educational and surgical guide purposes), bioprinting technology has not successfully 
printed yet any tissue constructs which were therapeutically relevant. The basic reason behind this fact is 
that besides the complexity of such an attempt, for each individual bioprinting technique there are several 
disadvantages which cannot be surpassed. Potentially a combination of multiple bioprinting techniques, as 
well as the combination of 3D bioprinting with other methods that are tested and used for tissue 
engineering, can provide a better strategy towards overcoming the constraints to reach the final aim and 
3D print a functional heart.  
 
3. Heart-on-chip systems 
This part focuses on surveying characteristic LoC systems that have been reported as cardiac models. Using 
microfluidic technologies, it is possible to better decipher human heart function and create more-relevant 
disease models and drug screening systems, which simulate tissue structure and function at a micron level 
and bridge the gap between the in vivo and in vitro worlds. Bioinspired microfluidic environments allow 
spatiotemporal control of various chemical and physical culture conditions that are unavailable with 
standard static cell cultures. Perfusion bioreactor systems with controlled oxygen supply closed to the in 
vivo environment, can overcome the limitations of diffusional transport in conventional culture systems as 
reported by Radisic et al. [149]. In the same context, Wang et al. studied the effect of shear stress within 
PDMS-based microfluidic chips with channels of various widths on the function of aortic valvular interstitial 
cells [150]. It was revealed the intensity of shear stress regulates cells morphology, transformation as well 
as the formation of focal adhesions. 
The importance of LoC platforms is indicated by the fact that drug testing in animal models cannot 
accurately predict the effects of drugs on humans. Characteristically only a small percentage manages to 
pass to the clinical phase [151]. Therefore, the development of human models in vitro is of paramount 
importance for effective drug development and the advances in microfabrication and microfluidics can 
make this possibility feasible. Herein the presented  “ŚĞĂƌƚ-on-ĐŚŝƉ ?ƐǇƐƚĞŵƐare categorized according to 
their main functionalities as electrical and mechanical stimulation based systems. Thereafter more complex 
systems supporting co-culture of cardiomyocytes with other cells are presented, as well as some distinctive 
cardiac-applied microfluidic approaches. 
 
3.1 Electrical stimulation systems 
Devices incorporating micro-electrodes for the stimulation of cardiomyocytes have been utilized for 
achieving better cell orientation and maturation but also for performing electrophysiology experiments. For 
the latter, MEAs have been applied for the extracellular recording of field potentials from the contracting 
cardiomyocytes, a crucial parameter for identifying arrhythmias caused by drugs which is in alliance with 
tŚĞ&ŝŶŝƚŝĂƚŝǀĞ “ŽŵƉƌĞŚĞŶƐŝǀĞŝŶ-ǀŝƚƌŽWƌŽĂƌƌŚǇƚŚŵŝĂƐƐĂǇ ? ?ŝW ?[152]. Herein we present the main 
microfluidic devices used for inducing electrical stimulation to cardiac cells. It must be noted that our 
search was focused solely in LoC systems containing microfabricated electrodes and not macro-scaled ones. 
One of the first microfluidic devices for achieving CMs anisotropy was reported by Yang et al., based on the 
combination of dielectrophoresis and electro-orientation [153]. They fabricated interdigitated Wcastellated 
microelectrodes by standard photolithography and lift-off on glass slides, which were sealed with silicone in 
order to create a perfusion chamber (figure 6(i)). By applying an appropriate frequency in a low conductive 
medium, adult rat CMs were trapped and oriented along the ac electric field direction and formed a tissue-
like structure. Cheng et al., studied the metabolic monitoring of adult rabbit CMs in a microfluidic device 
with integrated lactate sensor and stimulating microelectrodes [154]. The microfluidic chambers were 
designed in order to enable single cell manipulation and measure its contraction, intracellular calcium 
transients, pH and the released intracellular lactate after stimulation. Using this microfabricated PDMS-on-
glass chip, they demonstrated the effect of the restricted extracellular volume on the metabolic activity 
during continuous stimulation in an ischaemia cellular model.  
Tandon et al. developed a bioreactor system containing indium tin oxide (ITO) MEAs which were 
microfabricated using excimer laser ablation for the electrical stimulation of neonatal rat CMs and human 
adipose tissue-derived stem cells (hASCs) [155]. ITO advantages are the excellent electrical conductivity 
along with optical transparency. It was demonstrated that both cell types exhibited enhanced elongation 
and alignment after 6 days of electrical stimulation. Ma et al. combined laser-patterning and soft 
lithography to develop multiple muscle fibers (from neonatal rat CMs) with cell bridges on MEA chips, 
which allowed on chip analyses of electrical conductivities between different cell types in the myocardium 
[156]. The cell number for bridge formation was controlled by laser-patterning, and their results indicated 
that stem-cell (rat mesenchymal stem cells from bone marrow, rMSCs-bm) bridges conducted stronger 
electrical signals in comparison to fibroblast ones. 
Qian et al., demonstrated a cardiac platform that combined a MEA for field potential readouts and an 
interdigitated electrode (IDE) array for impedance readouts [157]. Both the MEA and IDEs were patterned 
on glass using standard photolithography and electron beam evaporation and were designed to be 
 “ŝŶƚĞƌƉĞŶĞƚƌĂƚŝŶŐ ?ƐŽƚŚĂƚƚŚĞǇŵĞĂƐƵƌĞƚhe same area of the tissue (figure 6(ii)). This platform was used 
for performing electrophysiology and contractility measurements of hiPSC-CMs. under physiological 
conditions and under drug stimuli. In specific the effect of norepinephrine, a clinical drug used to treat low 
blood pressure and heart failure, indicating that this platform can be used for cardiac toxicity studies. 
Another approach included the micromolding of gelatin on top of a commercial MEA [158]. This approach 
enabled the realization of electrophysiological measurements on laminar cardiac tissue resembling the 
native myocardium, in contrast to the previous studies that cells were cultured on the high-stiffness glass 
slide-MEAs. The system was validated by measuring the response of hiPSC-CMs in the presence of 
cardiotoxic pro-drug (terfenadine) and its non-cardiotoxic metabolite (fexofenadine), and proved to be 
capable in detecting small molecule-mediated differences in the cardiac tissue electrophysiological 
properties. The gelatin-micromolded MEA was further integrated in a microfluidic chip and tested by 
recording the response of this engineered tissue to isoproterenol (figure 6(iii)). The reusability of this 
system and its designing to support open-well cell culture for more precise cell seeding makes it a valuable 
platform for drug assessment. 
Concluding, electrical stimulation using microfabricated electrodes, mainly MEAs, clearly enhanced the 
structure and alignment of cardiac cells. The LoCs systems used are mainly based on PDMS bonded on thin 
glass where the latter contains the electrodes part. This scheme proved to be practical for living imaging 
studies, such the acquisition of the contracted cardiomyocytes and extracellular recording of field 
potentials. 
 
(i) 
 
(ii) 
 
(iii) 
 
Figure 6. Main electrical stimulation heart-on-chip systems: (i) Dielectrophoresis and electro-orientation on chip, 
reprinted with permission from [153]. (ii) hiPSC-CM tissue growth on a combined MEA-IDE chip. Scale bar: a. 1 cm, b.1 
ŵŵ ? Đ ? Ě ? ŝƐ  ? ? ? ʅŵ ? ůƵĞ P ŶƵĐůĞŝ ? ŐƌĞĞŶ P ĐĂƌĚŝŽŵǇŽĐǇƚĞ ƚƌŽƉŽŶŝŶ-T, reprinted with permission from [157]. (iii) 
Micromolded gelatin on a commercial MEA chip, reprinted with permission from [158]. 
 
3.2 Mechanical stimulation systems 
Except from the electrical stimulation, myocardium withstand mechanical loads due to the 
contraction/relaxation phases during each heartbeat. Various systems have been developed trying to 
reproduce this cyclic uniaxial strain that cardiomyocytes are subjected along the locally oriented ECM 
fibrous network. 
Marsano e al. presented a PDMS-based microfluidic device which mimics the in vivo mechanical stimulation 
of myocardium and applied to the 3D culture of neonatal and hiPSC-CMs [159]. The device contains an 
array of hanging posts to confine cell-laden fibrin gels, and a pneumatic actuation system to induce 
homogeneous uniaxial cyclic strains to the 3D cell constructs during culture (figure 7(i)). The mechanically 
stimulated microtissues showed early spontaneous synchronous beating and better contractile capability in 
response to electric pacing. A custom made electrical stimulator was utilized via connecting carbon rod 
electrodes to the constructs.  The microsystem was further evaluated by testing different concentrations of 
isoproterenol, a commonly used drug for bradycardia, and the results indicated that it can be a promising 
tool for drug testing in the future. 
Giridharan et al. developed a microfluidic cardiac cell culture model that replicates the physiological in vivo 
ďŝŽŵĞĐŚĂŶŝĐĂů ĐƵĞƐďǇŵŝŵŝĐŬŝŶŐ ƚŚĞŚĞŵŽĚǇŶĂŵŝĐ ƐƚƌĞƐƐĞƐĚƵƌŝŶŐƉƌĞƐƐƵƌĞALǀŽůƵŵĞĐŚĂŶŐĞƐ ŝŶ ƚŚĞ ůĞĨƚ
ventricle [160]. The system consisted of a cell culture chamber sandwiched between two rigid plates and 
integrated within a flow loop. The cells were cultured on a thin PDMS membrane placed at the bottom of 
the culture chamber, and the device was fabricated in such a way to permit the membrane to deflect and 
stretch. Both membrane and chamber were fabricated by soft lithography. This microfluidic system has 
shown that improved the structural and functional maturation of chick embryonic ventricular CMs in 
comparison to static cultures. It was also demonstrated the importance of mechanical stimulation on 
maintaining  intracellular calcium regulation and enhancing protein synthesis of embryonic chick CMs 
during embryogenesis [161]. The same group further improved the system by creating a more physiological 
environment by depositing matrigel/collagen on the chamber, and their results indicated that gradual 
mechanical loading in a nutrient-rich environment is required for the survival of hiPSC-CMs under 
physiologically relevant hemodynamic stress [162]. 
A 3D cardiac ʅtissue within a microfluidic device based on a micropatterning technology was presented by 
Aung et al. for the real-time contractile stress assessment [163]. Neonatal mouse CMs were encapsulated 
within a GelMA hydrogel, which was sandwiched between two polyacrylamide gels, where the latter 
ǁŽƌŬĞĚ ĂƐ  “ƐƚƌĞƐƐ ƐĞŶƐŽƌƐ ? ĨŽƌ ĂĐƋƵŝƌŝŶŐ ƚŚĞĐŽŶƚƌĂĐƚŝůĞ ƐƚƌĞƐƐĞƐ ƚŚĂƚ ŐĞŶĞƌĂƚĞĚ ďǇ ƚŚĞ DƐĐŽŶƚƌĂĐƚŝŽŶ ?
This trilayer gel was surrounded by microfluidic channels made by soft lithography, thus creating perfused 
cardiac cell-laden structures. Drug test using epinephrine, an adrenergic neurotransmitter known to 
increase the magnitude and frequency of cardiac contractions, demonstrated that the cardiac tissue 
construct exhibited an increased beating frequency and stress magnitude. Nevertheless, further 
improvement of the system is required in order to achieve better structural properties of the encapsulated 
CMs. 
Hansen et al. presented one of the first engineered heart tissues (EHT) constructed on PDMS post racks 
[164]. They simply added a mixture of neonatal rat heart unpurified cells, fibrinogen/Matrigel and thrombin 
into rectangular casting molds in which two PDMS posts were positioned from above. This method enabled 
the creation of EHT in a strip format that generates force under auxotonic stretch conditions. This 
technique enabled the automatic evaluation of the contractility and the evaluation of proarrhythmic 
(quinidine and erythromycin) and cardiotoxic (doxorubicin) effects of drugs. This EHT was further improved 
and tested with hiPSC-CMs and commercialized by the company EHT Technologies GmbH [165] [166]. 
Parker group pioneered in developing the technology of muscular thin films (MTF) which consist of 2D 
bilaminate constructs with an anisotropic tissue composed of muscle cells cultured on a deformable PDMS 
thin film coated (or microcontact printed) with fibronectin [167] [168]. The deformation of the MTF was 
associated to the contractility of the tissue, while its extent was depended on film geometry and tissue 
organization. They further advanced the throughput of the MTF technology and integrated it in a fluidic 
microdevice with a heated metallic base for maintaining physiological temperatures, transparent top for 
optically recording MTF deformation and embedded electrodes for electrical field stimulation of the tissue 
(figure 7(ii)) [169] ? dŚŝƐ ƉůĂƚĨŽƌŵ ǁĂƐ ƵƐĞĚ ƚŽ ƚĞƐƚ ƚŚĞ ĞĨĨĞĐƚ ŽĨ ƚŚĞ ɴ-adrenergic receptor agonist 
isoproterenol on the contractility of neonatal rat ventricular CMs. Moreover, Wang et al. used the 
technology of MTF for modeling the mitochondrial cardiomyopathy of Barth syndrome, a mitochondrial 
disorder caused by mutation of the gene encoding tafazzin (TAZ) [170]. Thin PDMS films with patterned 
lines of fibronectin led to self-organized into anisotropic myocardial tissues upon culture of iPSC-CMs onto 
them. By using Barth Syndrome iPSC-CMs, they manage to elucidate the metabolic, structural and 
functional abnormalities associated with TAZ mutation, providing new insights into this  cardiac disease 
pathogenesis. The same group recently demonstrated a device made by direct ink writing multimaterial 3D 
printing which was utilized for the continuous monitoring of cardiac micro-tissue contractile stress (figure 
7(iii)) [134]. The microphysiological device included multilayer cantilevers, readout electrical interconnects 
and independent wells. The cantilevers consisted of a base layer, an embedded strain sensor and a tissue-
guiding layer which contained grooved microstructures. Neonatal rat ventricular myocytes and hiPSC-CMs 
culture and drug testing with the L-type calcium channel blocker verapamil and isoproterenol 
demonstrated the functionality of this approach even at long-term cultures and thicker microtissues, 
rendering it a really promising platform for drug screening research. 
 
(i) 
 
(ii)
 
(iii
 
(iv) 
 
Figure 7. Characteristic mechanical stimulation heart-on-a-chip systems: (i) Design of the 3D heart-on-a-chip 
microdevice with a pneumatic actuation system for inducing uniaxial cyclic strains to the 3D cell constructs, reprinted 
with permission from [159]. (ii) Higher throughput heart on a chip and fluidic microdevice based on MTFs consisted of 
2D bilaminate constructs with an anisotropic tissue composed of CMs cultured on a deformable PDMS thin film, 
reprinted with permission from [169]. (iii) Direct ink writing multimaterial 3D printing on a MTF device: a) sketch of 
the device principle, b) fully printed final device, reprinted with permission from [134]. (iv) Pneumatic microfluidic 
platform for modeling cardiac hypertrophy; (A) electronic circuitry to control 4 bioreactors independently, (B) 
^ĐŚĞŵĂƚŝĐŽĨƚŚĞďŝŽƌĞĂĐƚŽƌƉůĂƚĨŽƌŵǁŝƚŚĂŶĂƌƌĂǇŽĨʅďŝŽƌĞĂĐƚŽƌƐ, ( ?^ĐŚĞŵĂƚŝĐĂŶĚŝŵĂŐĞƐŽĨƚŚĞĐĂƌĚŝĂĐʅƚŝƐƐƵĞ
formation, reprinted with permission from [171]. 
 
The Vunjak-Novakovic group developed a pneumatic microfluidic platform serving as model of cardiac 
hyperthrophy induced by volume overload (figure 7(iv)) [171]. Soft lithography techniques were employed 
ĨŽƌƚŚĞĨĂďƌŝĐĂƚŝŽŶŽĨʅďŝŽƌĞĂĐƚŽƌƐĂƌƌĂǇƐĐŽŶƚĂŝŶŝŶŐ ʅpillars, which facilitated the quick formation of large 
ŶƵŵďĞƌƐŽĨƐƚƌƵĐƚƵƌĂůůǇŽƌŐĂŶŝǌĞĚĐĂƌĚŝĂĐʅƚŝƐƐƵĞƐŝŶĂĚĞƐŝƌĞĚŐĞŽŵĞƚƌǇĂƐ  cells were induced to fuse into 
ʅƚŝƐƐƵĞƐĂƌŽƵŶĚƚŚĞĞůĂƐƚŝĐʅpillars. In this study a mixture of neonatal rat CMs and cardiac fibroblasts was 
ĞŶĐĂƉƐƵůĂƚĞĚ ŝŶĐŽůůĂŐĞŶŐĞů ?ǇĂĚĚŝŶŐĂĐŽŶƚƌŽů ůĂǇĞƌ ?ƉŶĞƵŵĂƚŝĐĐŚĂŶŶĞůƐƵŶĚĞƌŶĞĂƚŚƚŚĞʅǁĞůůƐǁĞƌĞ
pressurized, deflecting the pillars and subjecting the tissues to mechanical stress. With this design each 
ŝŶĚŝǀŝĚƵĂů ʅǁĞůů ǁĂƐ ƐƵďũĞĐƚĞĚ ƚŽ Ă ƐƉĞĐŝĨŝĐ ƉƌĞĚĞƚĞƌŵŝŶĞĚ ƐƚƌĂŝŶ ĂŶĚ ĞŶĂďůĞĚ ƚŽ ƐƚƵĚǇ ƚŚĞ ĞĨĨĞĐƚƐ ŽĨ
mechanical stress on cardiac hypertrophy, by real-time on-chip analysis of the tissues phenotype. The 
reusability, high throughput studies (it accommodates 900 cardiac ʅtissues using a small number of cells) 
and non-contact mechanical stimulation are the main advantages of this device. The same group very 
recently reported that achieved advanced maturation of human cardiac tissue, upon using early-stage 
hiPSC-CMs in a platform containing PDMS pillars for the formation of cardiac tissues incorporated in fibrin 
gel [172]. 
As it is depicted in figure 7, in most of the works the concept for achieving mechanical stimulation is based 
on the mechanical deformation of elastomeric thin membranes or posts. Soft lithography is the main 
technique and, depending the approach, either PDMS was used as substrate for the formation of the heart 
tissue or as mechanical support for the formation of hydrogel-based tissues. The microfluidic systems were 
designed to achieve stretching of the fabricated tissues which not only mimics the native stress applied in 
the myocardium but also aided in the structural organization of the cardiomyocytes. These mechanical 
stimulation approaches are continuing to advance (see Table I) and the use of hiPSC-CMs have given a 
further boost to their successful applications in the modelling of cardiac diseases. 
 
3.3 Cardiac models of combined co-culture on chip  
Even though the vast majority of the heart-on-a-chip devices focused on mimicking the myocardium, 
studies on cardiovascular models as well as systems combining heart and other organ tissues have been 
reported the last years. Ellis et al. developed a microfluidic device to mimic the 3D human cardiac muscle 
and surrounding microvasculature by spatially controlled co-culture of CMs and endothelial cells, both 
derived from the same hiPSC line [173]. The microfluidic device was fabricated using PDMS bonded on glass 
and it consists of three channels separated by micro-posts (figure 8(i)). The CMs were encapsulated in a UV-
crosslinkable GelMA hydrogel and seeded on the central channel in order to create a 3D cardiac muscle 
model, while the endothelial cells were cultured in the side channels for mimicking the microvasculature by 
providing nutrients and oxygen through media flow. Cell culture indicated that CMs were viable and 
functional within the device up to 7 days, and were integrated with the endothelial cells, rendering it a 
promising model for cardiovascular disease studies. 
Menon et al. introduced an ECM patterning method based on the principle of capillary burst valve (CBV) for 
creating perfusable vascularized microchannels of various vessel geometries [174]. The ECM hydrogel 
loaded into the chamber stopped at the boundaries of a PDMS microchannel design due to the CBV 
principle, and formed a patterned cell culture channel with ECM sidewalls (figure 8(ii)). They studied the 
endothelial cell barrier permeability and neutrophil transendothelial migration using collagen-patterned 
endothelialized microchannels and they further developed a 3D endothelial Wsmooth muscle cell (EC WSMC) 
vascular model. Their results indicated the importance of perivascular cells in ECM remodeling and the 
efficacy of the method for the study of hemodynamics and cellular interactions in cardiovascular diseases. 
 
(i) 
 
(iii) 
 
(ii) 
 
Figure 8. Cardiomyocyte-endothelial co-culture systems: (i) Schematic of a microfluidic Myocardium-on-a-Chip 
designed to support controlled co-culture of CMs and endothelial cells, reprinted with permission from [173]. (ii) 
Flexible 3D ECM patterning using microfluidics for modeling the endothelial Wsmooth muscle cell vascular system, 
reprinted with permission from [174]. (iii) Schematics of fabrication of an endothelialized myocardium by combining 
GelMa hydrogel technology and 3D bioprinting, reprinted with permission from [175]. 
 
Khademhosseini group combined the GelMA hydrogel technology with 3D bioprinting towards creating an 
endothelialized myocardium which was integrated in a microfluidic bioreactor [175]. Endothelial cells 
(HUVECs) were bioprinted within alginate-GelMA microfibrous hydrogel scaffolds of controlled anisotropy. 
After their migration to the peripheries of the microfibers, CMs were seeded into the interstitial space of 
the endothelialized scaffold (figure 8(iii)). In this study both neonatal rat and hiPSC-CMs were utilized. The 
incorporation of the scaffolds to a microfluidic device demonstrated the positive effect of perfusion at low 
flow rate in cells viability, where dose-dependent responses of both CMs and endothelial cells were 
observed when treated with doxorubicin. This technology seems promising, nevertheless it should be 
optimized for obtaining hollow endothelialized microfibers. 
Maoz et al. demonstrated a microfluidic device with integrated MEAs and electrodes for transepithelial 
electrical resistance (TEER) measurements for the simultaneous measurements of cellular electrical activity 
and tissue barrier function, which are useful in understanding heart pharmacodynamics [176]. TEER 
measurements represent the ionic conductance of the paracellular junctions of a cellular monolayer, 
applied to all epithelial tissues including the endothelium [177]. The device included a MEA, first fluidic 
layer made of PDMS, followed by a PET membrane, top chip channel and the TEER electrodes. The channel -
separating PET membrane was covered with a monolayer of HUVEC, where underneath hiPSC-CMs were 
cultured on the MEA surface (figure 9(i)). Proof-of-concept tests with the inflammatory stimulus tumor 
necrosis factor alpha (TNF-ɲ ? Žƌ ŝƐŽƉƌŽƚĞƌĞŶŽů ŝŶĚŝĐĂƚĞĚ ŝƚƐ ĞĨĨŝĐĂĐǇ ŝŶ ĚĞƚĞĐƚŝŶŐ ƐŝŵƵůƚĂŶĞŽƵƐůǇ ĚǇŶĂŵŝĐ
alterations of vascular permeability and cardiac function on chip. 
 
 
 
(i) 
 
(ii) 
 
    
 
Figure 9. Cardiac-other tissues co-culture systems: (i) Integrated TEER WMEA microfluidic chip for the simultaneous 
recording of cellular electrical activity and tissue barrier function, reprinted with permission from [176]. (ii) Integrated 
Heart/Cancer on a Chip: left-fabrication scheme, right-microfluidic device, reprinted with permission from [178]. 
 
A soft lithography-based microfluidic device was fabricated with on-chip integration of pneumatic valves 
and a peristaltic micropump for establishing precision fluid flow by Kamei et al. in order to emulate the side 
effects of cancer drugs [178]. The casting mold of the perfusion layer was fabricated by a combination of 
the negative resist patterning and grayscale lithography using positive resist coating as shown in figure 9(ii). 
The system contained a set of cell culture chambers with a medium circulation system that mimics the 
blood circulatory system that interconnects various tissue cells. In the integrated heart/cancer on a chip 
device, human healthy heart cells (hCMs) and liver cancer cells (HepG2) were cultured in separate 
chambers. The designing of the device allowed the evaluation of the side effects of doxorubicin on heart 
cells caused by the production of toxic metabolites (doxorubicinol) by the HepG2 cells through their 
delivery to heart cells via the circulation loop. 
 
3.4 Other cardiac-applied microfluidic systems 
Another approach of drug screening is the use of clusters of hiPSC-CMs which are called cardiac bodies 
(CBs). Bergström et al. combined CBs in a microfluidic chip and tested the cardiotoxicity of doxorubicin, 
verapamil and quinidine on these 3D-clustered CMs [179]. The chip was fabricated with standard soft 
lithography techniques and designed in order to capture the CBs along a perfusion channel (figure 10(i)). By 
video imaging it was possible to automatically record the beating frequency for each captured CB and 
assess the effect of drugs on it in a label-free, non-invasive fashion. 
Moreover, LoC systems have been reported for CMs sorting, taking advantage of microfluidics 
functionalities. For example, Li et al. achieved to purify CMs derived from hiPSCs, which is critical for 
avoiding teratomas in clinical applications [180]. The device consisted of integrated microcolumns and 
ridge-like flow derivation structures, designed such a way that cells were forced to cross these structures, 
resulting in high efficiency and selective retention of a chosen cell population on the functionalized surfaces 
(figure 10(ii)). Like that undifferentiated hiPSCs were efficiently captured in this PDMS-based microfluidic 
device, while the recovered CMs viability was not affected. 
 
(i) 
 
(ii) 
 
 
(iii) 
 
Figure 10. Microfluidic devices for cardiac cells capture/separation: (i) capture of hiPSC-CMs clusters on chip which 
was used for drug testing, reprinted with permission from [179]. (ii) hiPSC-CMs purification on chip via capturing the 
undifferentiated cells, reprinted with permission from [180]. (iii) CMs sorting from rest cardiac cells of a neonatal rat 
heart based on deterministic lateral displacement, reprinted with permission from [181]. 
 
Zhang et al. developed a PDMS-based device for the separation of functional CMs from the rest cell 
populations that exist in the cardiac tissue isolated from neonatal rat hearts [181]. The separation was 
based on size using the principles of deterministic lateral displacement (figure 10(iii)) [182]. The 
functionality of the enriched CMs after sorting was demonstrated upon culture on commercial 3D collagen 
porous scaffolds, where they formed contractile cardiac patches. 
 
 
 
 
 
Table I. ŚĂƌĂĐƚĞƌŝƐƚŝĐƐŽĨ ?,ĞĂƌƚŽŶĂŚŝƉ ?ƐǇƐƚĞŵƐ ? 
Cells type 
Cells direct 
substrate/matrix 
Microfluidic 
building block 
materials 
Stimulation In vivo disease 
model 
Tested drugs 
Publication 
year 
Ref. 
Electrical Mechanical 
adult rat 
CMs 
glass slide 
silicone 
chamber (no 
details) glued 
on glass 
9     2007 [153] 
adult 
rabbit CMs 
glass slide 
PDMS bonded 
on glass 
9   ischaemia  2010 [154] 
neonatal 
rat CMs, 
hASCs 
collagen 
PDMS bonded 
on glass-MEA  
9     2010 [155] 
neonatal 
rat CMs, 
fibroblasts, 
rMSCs-bm 
fibronectin 
PDMS bonded 
on glass-MEA 
9     2012 [156] 
hiPSC-CMs fibronectin 
polystyrene 
chamber glued 
on glass-MEA 
9    norepinephrine 2017 [157] 
hiPSC-CMs 
micromolded 
gelatin 
PEEK well on 
commercial 
MEA 
9    
isoproterenol, 
terfenadine-
fexofenadine 
2016 [158] 
neonatal 
rat CMs, 
hiPSC-CMs 
fibrin gel PDMS 9  9   isoproterenol 2016 [159] 
chick 
embryonic 
CMs 
collagen PDMS  9    2013;  
2015 
[160]; 
[161] 
hiPSC-CMs 
matrigel-
collagen 
PDMS  9  
post 
myocardial 
infarction 
 2016 [162] 
neonatal 
mouse 
CMs 
GelMa PDMS  9   epinephrine 2016 [163] 
neonatal 
rat heart 
unpurified 
cells; 
hiPSC-CMs 
fibrin-matrigel PDMS 9  9   
quinidine, 
erythromycin, 
doxorubicin; 
rolipram, 
isoproterenol, 
verapamil 
2010;  
2016 
[164]; 
[165]   
neonatal 
rat CMs, 
hiPSC-CMs 
fibronectin 
Polycardonate 
top, Al bottom 
9  9   isoproterenol 2013 [169] 
neonatal 
rat CMs, 
hiPSC-CMs 
 
ABS or PLA 
printed wells 
and covers, 
PDMS gasket 
9  9   verapamil, 
isoproterenol 
2017 [134] 
neonatal 
rat CMs & 
cardiac 
fibroblasts 
collagen gel, 
fibrin gel 
PDMS  9  cardiac 
hypertrophy 
isoproterenol, 
angiotensin II, 
endothelin-1 
2017;  
2018 
[171]; 
[172]  
hiPSC-CMs 
& 
endothelial 
cells 
GelMA hydrogel, 
fibronectin 
PDMS bonded 
on glass 
9     2017 [173] 
HUVECs & 
SMC 
collagen, fibrin, 
matrigel 
PDMS   
vascular 
inflammation, 
atherosclerosis 
 2017 [174] 
neonatal 
rat, hiPSC-
CMs & 
alginate-GelMA 
PMMA 
supports, 
PDMS gaskets 
   doxorubicin 2016 [175] 
HUVECs 
hiPSC-CMs 
& HUVECs 
fbronectin 
PDMS bonded 
on glass-MEA 
9   vascular 
inflammation 
isoproterenol 2017 [176] 
hCMs, 
HepG2 
fibronectin, 
gelatin or 
matrigel 
PDMS bonded 
on glass 
  
doxorubicinol-
cardiac toxicity 
doxorubicin 2017 [178] 
CBs of 
hiPSC-CMs 
- 
PDMS bonded 
on glass 
   
doxorubicin, 
verapamil, 
quinidine 
2015 [179] 
 
Concluding, there is a high diversity of  “,ĞĂƌƚŽŶĂŚŝƉ ?ƐǇƐƚĞŵƐ that have been developed over the last 10 
years. Table I summarizes their main characteristics; type of cells used and their direct seeding 
substrate/scaffold, materials used for the microfluidic block, stimulation applied, disease model and tested 
drugs. The year of publication gives an overview of the evolution of the approaches used over the last 
decade. It must be noted that in the table I we included the material that the cells were seeded on (or 
encapsulated) as separate column from the microfluidic materials, as we wanted to correlate it with the 
type of materials reported in the section 2. Nevertheless, in the vast majority of the published studies the 
microfluidic chips were fabricated by standard soft lithography indicating its efficacy in lab-scale 
applications. 
 
Conclusions 
An overview of the micro and nanofabrication and microfluidics approaches that have utilized for 
developing systems for cardiac tissue engineering has been reported in this review. Firstly, the main 
fabrication methods applied in cardiac tissue engineering are presented and compared. Advantages and 
disadvantages of their use as fabrication methods are described, as well as great advancements and typical 
approaches used. Each method provides for specific functionalities to be achieved. Optical lithography, soft 
lithography and plasmas have provided tools for structural and chemical modification in planar two 
dimensional fashion. Lasers, electrospinning and 3D bioprinting have provided the capability to advance the 
fabrication even further, by providing the tools to fabricate structures into three dimensions. In several 
cases the combination of these techniques is employed, where additional functionalities or capabilities are 
needed from the construct.  
These approaches focused on culturing cardiac cells in a biomimetic environment in order to create a 
functional cardiac tissue. The main objective was to recapitulate the ECM that support cardiac cells and for 
this reason the substrates or scaffolds are based on polymeric materials. Depending on the capabilities of 
method, cardiac cells were seeded on top of micro-nanoengineered materials in 2D or 3D structures or 
encapsulated within the polymeric matrix. The 2D structures have provided with useful information on the 
effect of geometries on cardiac cells structural properties. The 3D scaffolds have been applied, although in 
a limited number, for cardiac cell therapy by means of implantation in animal models carrying a specific 
cardiac disease. The idea of this therapeutic direction is on restoring some functionality in heart scarred 
regions by providing a new pool of functional cardiac cells. This application falls under the category of 
cardiac regenerative medicine with final target the clinical trials by implanting the cellularized scaffolds to 
patients. 
The other main category of applications comprises the personalized therapy and drug discovery through 
the development of in vitro systems that mimic the natural heart microenvironment. The idea is to bui ld a 
system with cardiac cells derived from patients and then study the cardiac pathophysiology and test drugs 
in vitro. Advancements in iPSCs engineering and DNA editing have enabled the feasibility of this strategy, 
which can lead to the achievement of individual patient-ƚĂƌŐĞƚĞĚƚŚĞƌĂƉǇ ?/ŶĂĚĚŝƚŝŽŶ ?ƚŚĞŝŶǀŝƚƌŽ “,ĞĂƌƚŽŶ
Ă ŚŝƉ ? ƉůĂƚĨŽƌŵƐ ĐĂŶ ƉƌŽǀŝĚĞ ƵƐĞĨƵů ŝŶĨŽƌŵĂƚŝŽŶ ĨŽƌ ĞĨĨĞĐƚŝǀĞ ĚƌƵŐ ĚĞƐŝŐŶŝŶŐ ƚŚƌŽƵŐŚ ĐĂƌĚŝĂĐ ƚŽǆŝĐŝƚǇ
studies, avoiding for example drugs for cancer therapy that cause heart dysfunction. Therefore, depending 
ŽŶ ƚŚĞ ĂƉƉůŝĐĂƚŝŽŶ ? ĚŝĨĨĞƌĞŶƚ  “,ĞĂƌƚ ŽŶ Ă ŚŝƉ ? ƐǇƐƚĞŵƐ ŚĂǀĞ ďĞĞŶ ĚĞǀĞůŽƉĞĚ ? &Žƌ ĞǆĂŵƉůĞ ? ƐǇƐƚĞŵƐ
providing electrical stimulation were reported for electrophysiology studies, while microfluidic chips 
designed to apply mechanical stress were utilized for contractility and structural assessment studies. 
Moreover, LoCs incorporating both electrical and mechanical stimulation to cardiac cells have been 
reported, thus providing a higher degree ŽĨŝŶƚĞŐƌĂƚŝŽŶƚŽǁĂƌĚƐƚŚĞĚĞǀĞůŽƉŵĞŶƚŽĨŵŽƌĞƌĞĂůŝƐƚŝĐ “,ĞĂƌƚ
on a ŚŝƉ ? ƐǇƐƚĞŵƐ ?Thereafter, taking advantage of the capabilities that microfluidics offer, systems for 
mimicking specific diseases such as pathological cardiac hypertrophy and ischaemia have started to be 
developed. Actually, some of the described micro/nanofabrication technologies have been incorporated to 
the microfluidic systems, such as microcontact printed molded structures, as well as bio-printed 3D 
scaffolds, even though these cases pose the minority. We envisage that the prior knowledge and the 
correct translation of the information extracted from the use of micro/nanoengineering in cardiac tissue 
engineering can lead to the development of multi-ĚŝǀĞƌƐĞ  “,ĞĂƌƚ ŽŶ ŚŝƉ ? ƐǇƐƚĞŵƐ ƚĂĐŬůŝng a wide 
spectrum of cardiac diseases.  
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